Rotarix vaccine oral syringe 1.5ML
Ended Awarded
- Contract number
- SPE2DB25FEQR3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,075
Award facts
- Contract value 100% obligated
- $11,074.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,074.95 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine oral syringes (1.5mL). The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of May 30, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement that extends through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a major healthcare solutions provider, the company maintains an extensive portfolio of federal contract awards encompassing vaccines, specialty medications, generic and brand-name drugs, and medical supplies across multiple therapeutic domains. The current delivery order for Rotarix vaccine syringes supports DLA's medical supply chain operations, which serve customers including the Defense Health Agency and U.S. Coast Guard. The award reflects AmerisourceBergen's established capability to meet federal procurement requirements through open competition and its role as a preferred vendor within the Defense Logistics Agency's pharmaceutical acquisition strategy.
Quick answers
Who was awarded contract SPE2DB25FEQR3?
SPE2DB25FEQR3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 29, 2025.
How much is contract SPE2DB25FEQR3 worth?
The government has obligated $11,075 on SPE2DB25FEQR3.
Is contract SPE2DB25FEQR3 an order under another contract?
Yes. SPE2DB25FEQR3 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FEQR3 competed?
The extent of competition for SPE2DB25FEQR3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award